EDGAR filings
Every filing EDGAR's full-index lists, from every filer: companies, insiders, funds and filing agents. A search that names no form type, ticker or filer CIK covers at most 31 days and defaults to the last 7.
EDGAR holds what was filed electronically. Electronic filing began in 1993 (the earliest filing here is of 1993-02-11) and was phased in filer by filer until May 1996: filings made on paper before 1993, and during the phase-in by a filer not yet on EDGAR, are not on EDGAR and therefore not here.
50 rows on this page.
| Filed | Form | Filer | Category | 8-K items / description | Accession |
|---|---|---|---|---|---|
| 2026-10-21 | 6-K |
SXTC
China SXT Pharmaceuticals, Inc.
CIK 1723980
|
Current reports | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-111404 |
| 2026-10-15 | SCHEDULE 13G |
SXTC
China SXT Pharmaceuticals, Inc.
CIK 1723980
|
Ownership | 0001493152-26-047269 | |
| 2026-10-09 | 6-K |
SXTC
China SXT Pharmaceuticals, Inc.
CIK 1723980
|
Current reports | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-108557 |
| 2026-10-09 | 424B5 |
SXTC
China SXT Pharmaceuticals, Inc.
CIK 1723980
|
Registrations and prospectuses | 0001213900-26-108254 | |
| 2026-10-08 | 6-K |
SXTC
China SXT Pharmaceuticals, Inc.
CIK 1723980
|
Current reports | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-107829 |
| 2026-10-08 | 6-K |
SXTC
China SXT Pharmaceuticals, Inc.
CIK 1723980
|
Current reports | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-107719 |
| 2026-09-16 | EFFECT |
SXTC
China SXT Pharmaceuticals, Inc.
CIK 1723980
|
Registrations and prospectuses | 9999999995-26-002978 | |
| 2026-08-28 | F-3/A |
SXTC
China SXT Pharmaceuticals, Inc.
CIK 1723980
|
Registrations and prospectuses | 0001213900-26-095149 | |
| 2026-08-28 | 6-K |
SXTC
China SXT Pharmaceuticals, Inc.
CIK 1723980
|
Current reports | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-095147 |
| 2026-07-24 | 6-K |
SXTC
China SXT Pharmaceuticals, Inc.
CIK 1723980
|
Current reports | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-081405 |
| 2026-07-24 | 424B5 |
SXTC
China SXT Pharmaceuticals, Inc.
CIK 1723980
|
Registrations and prospectuses | 0001213900-26-081135 | |
| 2026-07-07 | F-3 |
SXTC
China SXT Pharmaceuticals, Inc.
CIK 1723980
|
Registrations and prospectuses | 0001213900-26-075977 | |
| 2026-07-06 | 6-K |
SXTC
China SXT Pharmaceuticals, Inc.
CIK 1723980
|
Current reports | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-075528 |
| 2026-07-01 | 20-F |
SXTC
China SXT Pharmaceuticals, Inc.
CIK 1723980
|
Financial reports | ANNUAL REPORT | 0001213900-26-074310 |
| 2026-06-01 | 6-K |
SXTC
China SXT Pharmaceuticals, Inc.
CIK 1723980
|
Current reports | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-063591 |
| 2026-06-01 | 424B5 |
SXTC
China SXT Pharmaceuticals, Inc.
CIK 1723980
|
Registrations and prospectuses | 0001213900-26-063590 | |
| 2026-05-04 | 6-K |
SXTC
China SXT Pharmaceuticals, Inc.
CIK 1723980
|
Current reports | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-051679 |
| 2026-04-27 | 3 |
SXTC
China SXT Pharmaceuticals, Inc.
CIK 1723980
|
Ownership | 0001213900-26-048007 | |
| 2026-04-27 | 3 |
SXTC
China SXT Pharmaceuticals, Inc.
CIK 1723980
|
Ownership | 0001213900-26-048006 | |
| 2026-04-27 | 3 |
SXTC
China SXT Pharmaceuticals, Inc.
CIK 1723980
|
Ownership | 0001213900-26-048005 | |
| 2026-04-27 | 3 |
SXTC
China SXT Pharmaceuticals, Inc.
CIK 1723980
|
Ownership | 0001213900-26-048003 | |
| 2026-04-27 | 3 |
SXTC
China SXT Pharmaceuticals, Inc.
CIK 1723980
|
Ownership | 0001213900-26-048001 | |
| 2026-04-27 | 3 |
SXTC
China SXT Pharmaceuticals, Inc.
CIK 1723980
|
Ownership | 0001213900-26-048000 | |
| 2026-04-27 | 3 |
SXTC
China SXT Pharmaceuticals, Inc.
CIK 1723980
|
Ownership | 0001213900-26-047998 | |
| 2026-04-09 | 424B5 |
SXTC
China SXT Pharmaceuticals, Inc.
CIK 1723980
|
Registrations and prospectuses | 0001213900-26-041766 | |
| 2026-04-09 | 6-K |
SXTC
China SXT Pharmaceuticals, Inc.
CIK 1723980
|
Current reports | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-041765 |
| 2026-01-13 | 6-K |
SXTC
China SXT Pharmaceuticals, Inc.
CIK 1723980
|
Current reports | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-003910 |
| 2026-01-12 | 424B5 |
SXTC
China SXT Pharmaceuticals, Inc.
CIK 1723980
|
Registrations and prospectuses | 0001213900-26-003205 | |
| 2025-12-31 | 6-K |
SXTC
China SXT Pharmaceuticals, Inc.
CIK 1723980
|
Current reports | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-25-127097 |
| 2025-11-14 | EFFECT |
SXTC
China SXT Pharmaceuticals, Inc.
CIK 1723980
|
Registrations and prospectuses | 9999999995-25-003288 | |
| 2025-11-10 | F-3 |
SXTC
China SXT Pharmaceuticals, Inc.
CIK 1723980
|
Registrations and prospectuses | 0001213900-25-108285 | |
| 2025-11-10 | POS AM |
SXTC
China SXT Pharmaceuticals, Inc.
CIK 1723980
|
Registrations and prospectuses | 0001213900-25-108213 | |
| 2025-08-07 | SCHEDULE 13G |
SXTC
China SXT Pharmaceuticals, Inc.
CIK 1723980
|
Ownership | 0001213900-25-072841 | |
| 2025-08-07 | SCHEDULE 13G |
SXTC
China SXT Pharmaceuticals, Inc.
CIK 1723980
|
Ownership | 0001213900-25-072838 | |
| 2025-08-07 | SCHEDULE 13G |
SXTC
China SXT Pharmaceuticals, Inc.
CIK 1723980
|
Ownership | 0001213900-25-072835 | |
| 2025-08-07 | SCHEDULE 13G |
SXTC
China SXT Pharmaceuticals, Inc.
CIK 1723980
|
Ownership | 0001213900-25-072832 | |
| 2025-07-31 | 20-F |
SXTC
China SXT Pharmaceuticals, Inc.
CIK 1723980
|
Financial reports | ANNUAL REPORT | 0001213900-25-069688 |
| 2025-07-29 | 6-K |
SXTC
China SXT Pharmaceuticals, Inc.
CIK 1723980
|
Current reports | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-25-068429 |
| 2025-07-15 | 6-K |
SXTC
China SXT Pharmaceuticals, Inc.
CIK 1723980
|
Current reports | CURRENT REPORT | 0001213900-25-064149 |
| 2025-06-16 | 6-K |
SXTC
China SXT Pharmaceuticals, Inc.
CIK 1723980
|
Current reports | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-25-054611 |
| 2025-05-19 | 424B5 |
SXTC
China SXT Pharmaceuticals, Inc.
CIK 1723980
|
Registrations and prospectuses | 0001213900-25-045088 | |
| 2025-05-13 | 6-K |
SXTC
China SXT Pharmaceuticals, Inc.
CIK 1723980
|
Current reports | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-25-042394 |
| 2025-05-07 | 424B5 |
SXTC
China SXT Pharmaceuticals, Inc.
CIK 1723980
|
Registrations and prospectuses | 0001213900-25-040407 | |
| 2025-03-28 | S-8 |
SXTC
China SXT Pharmaceuticals, Inc.
CIK 1723980
|
Registrations and prospectuses | 0001013762-25-003930 | |
| 2025-03-28 | 6-K |
SXTC
China SXT Pharmaceuticals, Inc.
CIK 1723980
|
Current reports | REPORT OF FOREIGN PRIVATE ISSUER | 0001013762-25-003583 |
| 2025-03-19 | 6-K |
SXTC
China SXT Pharmaceuticals, Inc.
CIK 1723980
|
Current reports | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-25-024830 |
| 2025-01-27 | 6-K |
SXTC
China SXT Pharmaceuticals, Inc.
CIK 1723980
|
Current reports | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-25-006976 |
| 2025-01-23 | 6-K |
SXTC
China SXT Pharmaceuticals, Inc.
CIK 1723980
|
Current reports | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-25-005977 |
| 2025-01-21 | SCHEDULE 13G/A |
SXTC
China SXT Pharmaceuticals, Inc.
CIK 1723980
|
Ownership | 0001851416-25-000004 | |
| 2024-11-04 | EFFECT |
SXTC
China SXT Pharmaceuticals, Inc.
CIK 1723980
|
Registrations and prospectuses | 9999999995-24-003364 |